Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The manuscript is original and has not been published (even in part, for example only the abstract) in other journal or conference proceedings identified by DOI.
  • The submission files with the main text, Figure captions and Tables are in Microsoft Word format.
  • Whenever available, all references include the DOI.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

The electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports (ISSN-2764-734X) is an initiative of the Emilio Ribas Studies Center (Centro de Estudos Emilio Ribas – CEER) in partnership with GN1 Sistemas e Publicações Ltda EPP. 
 
Authors are asked to strictly follow the editorial standards of the Journal described below, particularly regarding the maximum number of authors, words, tables and figures allowed, as well as the rules for bibliographic references. Failure to comply with the editorial instructions will result in the return of the manuscript by the Editors for the authors to make the relevant corrections before submitting it to the reviewers. 
 
Articles that do not present merit, which contain significant methodological errors, or that do not fit the editorial policy of the Journal may be rejected by the Editor-in-Chief and/or Associate Editors, with no appeal. 
 
1. PRESENTATION
The electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports is intended for the publication of case reports involving any context of health care in an explicit interface with Infectious Diseases itself and its related areas. Case series (more than three) and other forms of scientific work (retro or prospective studies, literature reviews, etc.) are not candidates and will not be accepted for publication in the Journal, unless otherwise decided by the editors. 
 
The motivation to report a case stems from the professional's experience in treating patients with rare diseases or academic interest, when there is a diagnostic challenge, when adverse effects or complications arise during treatment, in the face of innovative procedures, or even in the case of frequent diseases with unusual evolution, when there are difficulties in their conduction and clinical resolution or that involve ethical, moral or legal dilemmas.
 
The articles will always be published in Portuguese and English, and can be written and submitted by the authors in either of these two languages - it is up to the production team of the Journal to provide its translation or version, as the case may be. The entire process of submission, evaluation, editorial work, translation, and publication of articles in INFECTOLOGIA EM EVIDÊNCIA is completely free for the authors and co-authors, with no fees or financial charges at any point during the process. 
 
Manuscripts, as well as other mandatory documents (Copyright Transfer Agreement, Conflict of Interests Statement and ethical approval of the institution of origin), must be submitted exclusively online through the site: http://infectologiaemevidencia.org/
 
2. AUTHORSHIP CRITERIA
The inclusion of an author in a manuscript submitted for publication is only justified if contributing significantly, from an intellectual point of view, to its realization. It is implied that the author participated in at least one of the following phases: 1) choice and conception of the Case Report itself; 2) writing and/or or reviewing the discussion in light of the interpretation of the evidence and comparison with the scientific literature; and 3) approval of the final version.
 
The concepts contained in the manuscripts are the sole responsibility of the authors, and they must answer for any and all questions. 
 
The electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports accepts a maximum of 6 (six) authors. In the case of a larger number of co-authors, the lead author should send a letter to the Editor-in-Chief describing the participation of each author in the work.
 
3. MANUSCRIPT SUBMISSION 
The main manuscript must be attached through the journal's submission platform on tab 5 - “Conteúdo - Upload”, necessarily in .DOC format, ARIAL font, size 10, and paragraphs with 1.5 spacing. Graphics and tables must be included in this same and only.DOC file (not as images), right after the References. All images should be attached individually on tab 6, “Anexos”, in .JPEG or .TIFF format, with the best possible resolution (visit the Tips on Images session on our Home Page). All other documents can be attached only in .PDF, .JPEG or .TIFF format.
The next Table summarizes all archives and documents (with respective formats) that are required for the submission of any article through the journal's platform:
 
ATTACHMENT Format Observations
Manuscript doc WITHOUT THE IDENTIFICATION OF AUTHORS OR INSTITUTION(S), withou the Abstract and the keywords
Figures and tables doc Included in the Manuscript, after the References, properly subtitled
Images jpeg, tiff Individually attached, separate from other files
Copyright Transfer Agreement pdf, jpeg, tiff Signed by the Lead Author
Declaration of Conflict of Interests pdf, jpeg, tiff Signed by the Lead Author
Institutional Ethical Approval pdf, jpeg, tiff -
Other documents pdf -
 
3.1. MANUSCRIPT IDENTIFICATION
The Journal's online submission tool collects the following information separately: the title of the manuscript (in Portuguese and English), full name (without abbreviations) and title of the authors, ORCID number (available at https://orcid.org), author’s affiliations, full address for contacting the lead author (address, telephone number and email), name of the funding body (if any), the abstract, as well as at least three keywords. 
 
3.1.1. TITLE: must be succinct, descriptive and precise, preferably limited to a maximum of 20 words. Abbreviations should be avoided whenever possible. The titles of the articles should not include the phrase "Case Report", as this is already explicit in the very design and configuration of the website of the Journal. Each published article, however, will have a .PDF version available for printing - in this case the expression "- Case Report" will be automatically added to the end of the original title provided by the authors.
 
3.1.2. ABSTRACT: should be short, limited to 200 words. Avoid abbreviations or references. The abstract should not be structured, but should initially present the main problem (citing the justification and importance of the case to be reported) followed by a quick description of the case itself, the eventual interventions performed, its respective evolution and the arguments that support the impact of the case presented.
 
3.1.3. KEYWORDS: should be provided with three to five keywords (in Portuguese or English) that define the subject of the manuscript, based on the DeCS (Health Sciences Descriptors, available at http://decs.bvs.br) database for the terms in Portuguese and the MeSH (Medical Subject Headings available at https://www.nlm.nih.gov/mesh/meshhome.html) database for terms in English.
 
3.2. COPYRIGHT TRANSFER AGREEMENT AND CONFLICTS OF INTEREST
The lead author must print the two documents available in the Journal site, complete them and sign the specific Form on behalf of all other co-authors and then scan and attach them individually (in .pdf or .jpg) to the online submission system of the Journal.
 
The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation.
 
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals. 
 
As for conflict of interest, this occurs when a professional's judgment on a primary interest (e.g., patient safety or scientific truth) may be influenced by some other secondary interest (e.g., financial gain or personal prestige). If there is any conflict of interest involving the authors, it needs to be explained. Otherwise, a declaration attesting to its exemption is also necessary.
 
3.3. INSTITUTIONAL ETHICAL APPROVAL
Institutional ethical approval consists of the declaration of acknowledgment and authorization by the institution of origin of the reported case and the opinion of the CEP/CONEP system based on Resolution 466/12 and/or other specific regulations, for example the CNS Carta Circular 166/2018. 
 
3.4. MANUSCRIPT
 
3.4.1. Body of Text: should not exceed 2.000 words (excluding title, abstract, bibliographic references and figures). Its structure should be composed of Introduction, Case Report, Discussion and Conclusion.
 
The Introduction should address the context of the Case Report with reference to the relevant medical literature and justify its scientific interest for publication. The introduction should ideally not exceed more than two paragraphs.
 
As for the Case Report proper, its redaction should be objective, taking into account the description of the facts and remaining constant until the outcome chosen by the author, and any information that suggests the identification of the patient should be suppressed. It is recommended that the initials of the patient or precise dates (day/month/year) should not be cited to protect the privacy and professional confidentiality of the individual portrayed, as well as to present only relevant data to illustrate the case and enrich the discussion.
 
The text should be straightforward, not structured, following a chronological and organized order in the narrative, eliminating superfluous data, details in excess and confusing or unconfirmed information. Initially, the patient must be characterized (sex, age, ethnicity and profession, if applicable) and past history and/or background (relevant personal or family), then the current history (complaint and duration), the physical examination (positive findings - negative, only if strategic), laboratory and image exams (making the call to the respective figures), procedures performed, treatment etc. If there is a didactic interest, the evolution of the facts can be presented in graphic form.
 
The patient's medical records (including the evolution recorded by the various professionals who provided him/her assistance, test results, prescription of treatments, etc.) is usually the main source of information in a Case Report, however other possibilities are also allowed and sometimes necessary (e.g., data from administrative notebooks and records of interviews already taken place). 
 
The Discussion aims to compare the Case Report with similar (or distinct) examples described in the literature, cite strengths and/or limitations in the conduct of the case, list diagnostic hypotheses and/or alternative conducts and treatments in such a way as to culminate in the Conclusion of the article, i.e., what are the main lessons that can be learned from this Report.
 
Note. 1: The identification of authors, institution(s) abstracts and keywords should not be included / repeated in the "main" file of the manuscript. 
Note. 2: With the exception of the measurement units commonly used, acronyms and abbreviations should be avoided to the fullest. If they need to be used, they should always be defined the first time they are mentioned, for example: C-reactive protein (CRP). After the abbreviation has been defined, the full term should no longer be used. 
Note. 3: When any commercial information or equipment is mentioned, data explaining the product (manufacturer's name, country of origin, etc.) should be provided. 
Note. 4: If there are reasons for acknowledgements and collaborations, they should be included as the last paragraph of the text, after the conclusions, in italics. 
 
3.4.2. Citations in the text: shall be numbered with Arabic numerals and in the order in which they were cited. The number of the citation must be placed at the end of the text, before the end point of the sentence, overwritten and without space between the last word and the number. Mention of the authors name should be avoided throughout the text, always giving preference to numerical citations only; if this is not possible, enter the citation number immediately after the author's name, without placing the publication year - example: according to Lacaz et al.5, the environment...
 
Sequential citations - the numerals should be separated with hyphen and, in interspersed citations, separated with comma, without spacing between the characters - example: infectious2,5,6-9.

Direct citations with up to three lines should be transcribed in quotation marks with the citation number at the end of the text, following the guidelines above. Citations with more than three lines should be transcribed in a specific paragraph, without quotation marks, with indentation of the left margin of 4 cm, simple spacing and font size smaller than the text of the article, followed by the respective citation number.
 
3.4.3. References: the maximum limit of bibliographic references is 20 (twenty). Only references used in the text should be indicated.
 
For all references, a maximum of six authors should be cited - if there is more, the expression et al. should be added.
The titles of the journals cited shall be abbreviated according to the list Journals Indexed in Index Medicus, of the National Library of Medicine, which is available at the address https://www.library.caltech.edu/journal-title-abbreviations.
 
The formatting of bibliographic references should be based on the Vancouver style, as shown below.

Original Articles:
Melo FAF, Afiune JB, Ide Neto J, Almeida EA, Spada DTA, Antelmo ANL, et al. Epidemiological aspects of multidrug-resistant tuberculosis in a referral service in the city of São Paulo. Rev Soc Bras Med Trop 2003; 36:27-34. https://doi.org/10.1590/S0037-86822003000100005 PS - as long as it exists, always include the doi address.
 
Book Chapters:
Bethlem N, Bethlem EP, Ribeiro SN, Gerhardt Filho G, Silva JRL, Souza GRM, et al. Tuberculose. In: Bethlem N, editor. Pneumologia. 4th ed. São Paulo: Atheneu; 1995. p. 379-448.
 
Meeting Proceedings:
Santos MA, Makibara RN, Formentin FS, Costa JS, Santana JRP, Moreira RS, et al. HIV / tuberculosis co-infection: the panorama in the state of Sergipe in the last 10 years [Internet]. In: Urban and global diseases. 52nd Congress of the Brazilian Society of Tropical Medicine; 21-24 ago 2016 [cited 22 Oct 2020], Maceió, AL. Available at: Click here.
or
Rice AS, Farquhar-Smith WP, Bridges D, Brooks JW. Canabinoids and pain. In: Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA. Seattle (WA): IASP Press; c2003. p. 437-68.

Theses/dissertations:
Figueiredo RCPS. Study of the use of the bacteriological method in the diagnosis of pulmonary tuberculosis in the city of Taubaté, S. Paulo [dissertation]. São Paulo: School of Public Health, University of São Paulo; 1996.
 
Official publications:
Ministry of Health (BR). Health Surveillance Secretariat. Department of Communicable Diseases Surveillance. Manual of recommendations for tuberculosis control in Brazil. 2nd ed. Brasilia: MS; 2019.

Content available exclusively on the Internet:
GN1 Sistemas e Publicações. Infectious Diseases in Evidence: Case Reports. Instructions for Authors [Internet]. Brasil; 2022 [Acessed September 18, 2023]. Available at: https://infectologiaemevidencia.org/instructions-for-authors 
 
3.4.4. Regarding the use of Artificial Intelligence (AI) tools:
the use of applications such as ChatGPT, Bard or others that are sure to come, whether to write, translate, review or edit academic manuscripts presents ethical challenges for researchers and journals. The use of AI is not intrinsically unethical and depends, above all, on the human being taking responsibility for what was transcribed, beside ensuring compliance with regulations. (text adapted from SPINAK E. Inteligência Artificial e a comunicação da pesquisa [online][PORT]. SciELO em Perspectiva, 2023 [viewed 5 November 2023]. Available from: https://blog.scielo.org/blog/2023/08/30/inteligencia-artificial-e-a-comunicacao-da-pesquisa/).
 
The electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports does not prohibit the use of Artificial Intelligence (AI) applications for writing manuscripts sent for publication, however it requires that, if applicable, the name of the AI tool and how it was used be explained as a note, at the end of the list of bibliographic references.
 
3.5. FIGURES AND TABLES
In accordance with their citation throughout the text, images and graphics must be attached individually, in a separate file of the Manuscript and the designation of each illustration identified in the text. The total number of figures, illustrations and/or tables should not exceed 6 (six).
 
Figures should preferably be attached in .jpg or .tiff format (read some "tips on images" on our website). Tables must be attached in .doc format, properly formatted, never as figures, images or in .pdf format.
Legends should accompany their images (photographs and illustrations) or tables. Each legend must be numbered in Arabic numerals, corresponding to its citations in the text (e.g., Figure 3). All abbreviations and acronyms used in the figures and tables must be defined in full below them. Quantities, units and symbols must comply with the corresponding national standards (http://www.abnt.org.br).
 
3.6. Below is a table with the main limits to be observed in the preparation of articles to be forwarded for publication in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports:
 
 
LIMITS:
Maximum number of authors 6 6
Maximum number of words in the Abstract 200
Maximum number of words in the Manuscript (Introduction, Case Report, Discussion and Conclusion) 2,000
Maximum number of references 20 20
Maximum number of figures and/or tables 6
 
4. OTHER DOCUMENTS
In the case of files to be attached without matching some of the categories listed above (such as letters and recommendations to the Editor-in-Chief), they must be formatted as ..doc or pdf files.
 
5. OTHER INFORMATION 
All manuscripts, after submission, will initially be evaluated by the Editors and then forwarded to reviewers specialized in the subject, and anonymity is guaranteed throughout the evaluation process. 
 
Each article will receive an internal registration number, exclusive to the electronic Journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided by the system itself online to facilitate their identification throughout the approval process. The chronological order of the publication of the approved articles, however, will not respect this sequence, because this determination is solely up to the Editor-in-Chief and/or Associated Editors.
 
The Journal reserves the right to make any adaptations of style, grammatical and other revisions to the accepted articles, under the professional commitment of always submitting the final version for approval by the authors before its effective publication.

Case Reports

Maximum number of authors: 6
Maximum number of words in the Abstract: 200
Maximum number of words in the Manuscript (Introduction, Case Report, Discussion and Conclusion): 2000
Maximum number of references: 20
Maximum number of figures and/or tables: 6

Copyright Notice

COPYRIGHT TRANSFER AGREEMENT

Privacy Statement

PRESENTATION

In this document, the term “website” will be used to refer to the website of  the INFECTIONS IN EVIDENCE - Case Reports Journal. The terms “we” or “our” relate to the website owners and the Editorial Board. Terms such as “you” or “your” are related to the website user, reader of this document. This document describes how the website works in order to collect, receive, classify, use, access, play, transmit, distribute, process, archive, store, delete, evaluate, control access to your modifications, communication, transfer, broadcast, or extract information. 

PERSONAL DATA COLLECTED

Your personal data on the website is under the control of the institution that holds the Journal, the Emílio Ribas Study Center. Genius Design acts as a data operator, handling your data on the website according to the institution’s instructions. Your personal data is basically information that identifies you, the data holder.

The personal data of the users collected in the register are full name, e-mail, institution, profession, login and password.

For security, all your actions on the system are logged, filing data related to your session, such as Internet Protocol Address (IP) and browser information, as well as web server logs, cookies, and other technologies used by Genius Design for product improvement, security, and troubleshooting.

USE OF PERSONAL DATA COLLECTED – PROCESSING

Genius Design processes the personal data inserted on the website only to provide our services for registration management. We do not use it for our own purposes.

Your personal data may be used for:

  • Sending announcements regarding alerts or moderation posts by managers;
  • Sending e-mails about password recovery or confirmation of the request to remove personal data;
  • Issuing statistical reports on the use of the website, pages, articles, and tools;
  • Sending e-mails about the Journal or related content to the Journal upon your consent to receive newsletters.

The institution responsible for the Journal may use your contact information to send informational e-mails to communicate events, promotions, or products of interest to the target public. Any marketing e-mail sent to you is the responsibility of the Emílio Ribas Study Center, and Genius Design uses it only for data processing on the website.

The website provides ways to obtain your consent to receive e-mail marketing communications. You can edit your registration at any time to revoke your consent to receive newsletters.

SHARING PERSONAL DATA WITH THIRD PARTIES

Your personal data on the website can be accessed by:

  • Genius Design employees and contractors whose professional role requires access to your data. Both are subject to confidentiality with legal data protection obligations.
  • Genius Design providers of server hosting services, web services, and databases. Any such suppliers are under confidentiality agreements with legal data protection obligations.
  • The institution that acts as the “controller” of your personal data through its employees, with access to register management.
    Third parties, such as the result of incorporations, corporate aggregation, or any corporate events involving Genius Design.
  • Competent authorities in the event of regular exercise of rights in judicial, administrative, or arbitral proceedings pursuant to Article 7, VI of Law No 13.709/2018.

SECURITY

Genius Design uses the best in security and development, using privacy in modeling our products by default, as well as encryption in data transfer between client and server, hosting services in internationally recognized companies, Server maintenance in Brazil and the United States, and good security practices at all stages of development, from design to publication.

However, we do not guarantee the security of misuse of the system by third parties who, authorized or otherwise, have in any way obtained access to the access data (login and password).

RIGHTS OF THE HOLDER

From the registration area of the user in the system you may, as provided for in Article 18 of Law 13.709/2018:

  • • Change or correct your registration information;
  • • Request the recovery of all history of user actions on the system;
  • • Revoke consent to receive newsletters (e-mail marketing);
  • • Request the deletion of your personal data.

If you ask to delete your data, your identification, name and e-mail, institution, and profession data will be deleted. 

DATA RETENTION PERIOD

The retention period will be as long as the institution uses the website. In the event of a breach/termination of the contract, your personal data will be removed from our servers within 60 days and will be converted into a file capable of portability to another vendor.

CONTACT US

It is recommended that the association be first contacted about questions or requests that involve the use of your personal data. If there is any suspicion of an act contrary to this policy or the current legislation, the data subject may report the suspected act directly to Genius Design by the e-mail: contato@geniusdesign.com.br